TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Ocumension Therapeutics ( (HK:1477) ).
Ocumension Therapeutics has announced a change in its principal share registrar and transfer office in the Cayman Islands, effective December 31, 2024, to Vistra (Cayman) Limited. This change reflects a strategic move in the company’s operational management, potentially impacting its administrative processes and stakeholder interactions.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry, focusing on the development and commercialization of ophthalmic products.
YTD Price Performance: -3.78%
Average Trading Volume: 1,523,524
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$3.49B
For an in-depth examination of 1477 stock, go to TipRanks’ Stock Analysis page.